Wai Chun Bio-Technology Limited (HKG:0660)
Hong Kong · Delayed Price · Currency is HKD 0.3850
+0.0050 (1.32%)
Sep 2, 2026, 4:08 PM HKT
Wai Chun Bio-Technology Ratios and Metrics
Market cap in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Dec '21 Dec 31, 2021 |
| 140 | 25 | 21 | 17 | 67 | 94 | |
Market Cap Growth | 320.84% | 14.91% | 22.55% | -73.98% | -28.57% | -29.96% |
Enterprise Value | 287 | 156 | 148 | 152 | 219 | 232 |
Last Close Price | 0.38 | 0.14 | 0.13 | 0.10 | 0.40 | 0.56 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 0.25 | 0.07 | 0.06 | 0.02 | 0.10 | 0.19 |
PB Ratio | -4.03 | -0.39 | -0.39 | 1.66 | 11.14 | -3.96 |
P/FCF Ratio | - | - | 1.78 | 0.84 | - | - |
P/OCF Ratio | 5.87 | 17.33 | 0.41 | 0.36 | 21.10 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.50 | 0.41 | 0.40 | 0.20 | 0.33 | 0.47 |
EV/EBITDA Ratio | 20.58 | 10.29 | 13.76 | 7.10 | 8.97 | 30.22 |
EV/EBIT Ratio | 45.65 | 41.83 | 91.49 | 12.78 | 12.18 | 142.65 |
EV/FCF Ratio | - | - | 12.30 | 7.35 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -4.09 | -1.52 | -2.46 | 12.75 | 25.06 | -6.20 |
Debt / EBITDA Ratio | 10.18 | 5.63 | 10.47 | 5.17 | 5.25 | 12.36 |
Debt / FCF Ratio | - | - | 11.28 | 6.49 | - | - |
Net Debt / Equity Ratio | -3.40 | -1.41 | -2.42 | 12.15 | 23.81 | -5.13 |
Net Debt / EBITDA Ratio | 8.84 | 5.85 | 12.43 | 5.97 | 5.88 | 15.92 |
Net Debt / FCF Ratio | -67.02 | -3.67 | 11.10 | 6.18 | -17.96 | -12.58 |
Asset Turnover | 2.80 | 1.78 | 1.65 | 3.16 | - | 2.64 |
Inventory Turnover | 13.30 | 5.36 | 4.83 | 8.34 | - | 7.71 |
Quick Ratio | 0.40 | 0.14 | 0.13 | 0.31 | 0.33 | 0.29 |
Current Ratio | 0.67 | 0.39 | 0.45 | 0.81 | 0.86 | 0.60 |
Return on Equity (ROE) | - | - | - | -121.40% | - | - |
Return on Assets (ROA) | 1.93% | 1.10% | 0.45% | 3.04% | - | 0.54% |
Return on Invested Capital (ROIC) | 14.38% | - | 3.44% | 8.27% | -7.37% | 4.76% |
Return on Capital Employed (ROCE) | 14.40% | -6.00% | -3.70% | 14.60% | 25.10% | 5.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -4.94% | -59.37% | -206.27% | -88.24% | -21.36% | -18.09% |
FCF Yield | -1.26% | -97.93% | 56.20% | 118.42% | -11.91% | -10.31% |
Buyback Yield / Dilution | -3.19% | -1.15% | -1.51% | -0.78% | -0.14% | -0.90% |